SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Ukraine
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

PoltavaPharm (Полтавафарм // с. Розсошенці)

Main Activities: Pharmacies and Drug Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
PoltavaPharm (Полтавафарм, Полтавське Обласне Кп)

Legal Address
vul. Horbanivska, 2; s. Rozsoshentsi; Poltavska region; 38751
Status: Non-Listed
Legal Form: Other non-liability limited
Operational Status: Operational
EGRPOU: UA-32986923
Incorporation Date: June 4, 2004

Tel: +38/0532/590289

Company Description

"PoltavaPharm" is communal pharmacy. It's principal business is manufacturing and distributing of medicines and other pharmaceutical products.

Company Analysis

According to the Individual - Audited financial statement for the Year of 2011, total net operating revenues increased with 7.09%, from UAH 232,944 thousands to UAH 249,464 thousands. Operating result increased from UAH 3,351 thousands to UAH 3,966 thousands which means 18.35% change. The results of the period decreased -1.98% reaching UAH 2,275 thousands at the end of the period against UAH 2,321 thousands last year. Return on equity (Net income/Total equity) went from 12.00% to 10.60%, the Return On Asset (Net income / Total Asset) went from 6.26% to 5.34% and the Net Profit Margin (Net Income/Net Sales) went from 1.00% to 0.91% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 98.38% compared to 91.71% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.89 to 1.81 when compared to the previous year.

Key Executives

Mykola Klius Director

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
2011 Y
(non-cons)
2010 Y
(non-cons)
Audited Audited
Unit Thousands Thousands
Balance Sheet

Total Assets

42,565

37,094

Current Assets

XX,XXX

XX,XXX

Total Liabilities

XX,XXX

XX,XXX

Shareholders Equity

XX,XXX

XX,XXX

Current Liabilities

XX,XXX

XX,XXX

* All the accounts are in UAH.
Income Statement

Total Operating Revenue

XXX,XXX

XXX,XXX

Operational Profit (Loss)

X,XXX

X,XXX

Net Profit (Loss)

X,XXX

X,XXX

* All the accounts are in UAH.
Ratios
Profitability Ratios

Return on Assets (ROA)

X.XX%

X.XX%

Annualised Return on Assets (ROA)

X.XX%

X.XX%

Return on Equity (ROE)

XX.X%

XX%

Annualised Return on Equity (ROE)

XX.X%

XX%

Return on Sales (ROS)

X.XX%

X.XX%

Return on Capital

XX.X%

XX.XX%

Gross Profit Margin

XX.XX%

XX.XX%

Operating Profit Margin

X.XX%

X.XX%

Efficiency Ratios

Accounts Receivable Turnover

XXX.XXx

XXX.XXx

Inventory Turnover

X.XXx

X.XXx

Current asset turnover

X.XXx

X.XXx

Fixed-asset turnover

XX.XXx

XX.XXx

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

X,XXX

X,XXX

EBITDA

X,XXX

X,XXX

Bookvalue (BV)

XX,XXX

XX,XXX

Net Cash

-XX,XXX

-XX,XXX

Liquidity Ratios

Current Ratio

XXX.X%

XXX.XX%

Quick ratio

XX.XX%

XX.XX%

Doom's day ratio

XX.XX%

XX.XX%

Cash Flow to Debt

XX.XX%

XX.XX%

Leverage Ratios

Leverage ratio

XXX.XX%

XXX.XX%

Debt to equity

XX.XX%

XX.XX%

Debt to total assets

XX.XX%

XX.XX%

Long Term Debt to Capital

X.XX%

X.XX%

Trend Ratios

Revenue Trend

XXX.XX%

Net Income Trend

XX.XX%

Operating Income Trend

XXX.XX%